Hgh performance liquid chromatography has shown that after intravenous injection cholesterol-poor liposomes (100 nm) are unstable and their phospholipid is redistributed.
We have previously shown that liposomes (microscopic phospholipid vesicles), which carry a net negative surface charge, given intravenously specifically accumulate in the inflamed paws of rats with adjuvant induced arthritis.' Liposomes of identical composition when isotopically labelled have also been shown scintigraphically to image the actively inflamed joints of patients with rheumatoid arthritis.2 3 The aim of these studies was to elucidate a liposome formulation with a high affinity for inflammatory tissue as well as establishing the underlying mechanism(s) responsible for the specific liposome accumulation found in the rat paws and the scintigraphic scans in rheumatoid arthritis. Previous liposome stability studies showed that cholesterol-poor liposomes were relatively unstable in serum, and a redistribution of the liposomal phospholipid was shown to occur.4 It is known that when a high ratio of cholesterol is incorporated into liposomes-for example, equimolar with the other phospholipids, condensed molecular packing occurs within the bilayers, which results in a more stable liposome structure.5 6 We have confirmed this finding and shown that negatively charged, cholesterol-rich liposomes are stable both in serum in vitro and in vivo. 4 to from blood samples taken four hours after injection was run on a TSK GSOOOPW HPLC column (fractionation range 7xl06-5xl10 daltons). Fractions were collected and counted for 99'Tc activity and the profiles obtained in vivo compared with the HPLC profiles of the liposomes which had been incubated separately at 37°C at a 1:100 dilution in rat serum and in saline.
Results Figure 1 shows the HPLC elution profiles of the cholesterol-poor and cholesterol-rich 100 nm liposomes four hours after intravenous injection into normal rats and after incubation in rat serum and in saline. In vivo and in rat serum the cholesterolpoor liposomes were reduced in size and radioactivity peaks were seen to enter the gel (fig IA) , whereas the cholesterol-rich liposomes were not reduced in size ( fig 1B) . Figure 2 shows the clearance of the cholesterolrich liposomes from the rat circulation. Although there were significant differences in the amount of uptake between the three cholesterolrich liposome preparations within normal paws, these did not bear any relation to the liposome size.
Some interesting points became apparent when the uptake of cholesterol-rich liposome by tissue The enhanced stability achieved by incorporation of a high concentration of cholesterol into liposomes is also well recognised,4 and the integrity of the liposome structure in vivo was shown by HPLC. The uptake of the cholesterolrich liposomes by inflamed paws was an important observation because it indicated that fully intact liposomes can gain access to inflamed tissue sites.
There were two major differences between the fate of cholesterol-rich and cholesterol-poor liposomes in vivo. The first was the relative stability (as assessed by HPLC) of the cholesterol-rich liposomes, whose structure remained unchanged, whereas in cholesterol-poor vesicles phospholipids were redistributed to lower molecular mass moieties. These moieties were found when incubation took place in serum, but they were not present in the profile obtained in vivo, presumably owing to removal from the rat circulation.
The second difference was in the uptake of liposomes by the spleen. It was found that 17-3% and 12-90/o of the total dose injected of 100 nm and 200 nm cholesterol-rich liposomes accumulated in the spleen compared with 6-1% and 5-1% for the 100 nm and 200 nm cholesterol-poor liposomes. Roerdink et al and Moghimi and Patel found a similar distribution in the spleen and a decrease in the uptake by the liver, and suggested that macrophages within these two organs may require different opsonising factors.
Their observed decrease in liver uptake was due to the fact that the animal groups receiving cholesterol-rich and cholesterol-free liposomes were killed at equivalent times, whereas this study compares liposome distribution after 80% clearance of each hlposome preparation.
Over 6% of the 100 nm cholesterol-poor liposomes accumulated in the kidneys-an amount significantly greater (p<0001) than the 2-5% uptake seen with the 100 nm cholesterolrich liposomes. This difference in renal uptake was not found with the 200 nm liposomes, so may be attributable to a reduction in the size of the 100 nm liposomes. A similar result was not seen with the 200 nm cholesterol-poor liposomes because ofincreased stability increasing liposome size.17 18 This finding coupled with the low molecular mass moieties found in vitro may explain the preferential accumulation of the 100 nm cholesterol-poor liposomes in normal paw tissue and the kidneys. The major observation drawn from this study is that cholesterol-rich liposomes accumulate in inflammatory tissue. The cholesterol-rich liposomes have been shown to remain structurally intact in vivo, and when injected intravenously up to 7% of the 100 nm vesicles specifically accumulated within the inflamed rat paws. The 
